Home > Insider Trading > Filing (0001179110-17-007104)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235010	Momenta Pharmaceuticals Inc	MNTA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229450	A Craig Wheeler	C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-05-10	1,852	$15.77	283,977	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	277,477	Indirect	Craig Wheeler Revocable Trust

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2016.
This transaction was executed in multiple trades at prices ranging from $15.50 to $15.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Reflects a decrease of 15,536 shares of MNTA common stock transferred to the Craig Wheeler Revocable Trust on March 2, 2017.
Reflects the transfer of 15,536 shares of MNTA common stock on March 2, 2017 to the Craig Wheeler Revocable Trust that were previously held directly by Mr. Wheeler.